Risk of respiratory syncytial virus in survivors with severe congenital diaphragmatic hernia

Pediatrics International

Volumn 50, Issue 4, 2008, Pages 459-463

  Masumoto, Kouji ^a   Nagata, Kouji ^a   Uesugi, Toru ^a   Yamada, Tomomi ^b   Kinjo, Tadamune ^a   Hikino, Shunji ^a   Hara, Toshiro ^a   Taguchi, Tomoaki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Bronchiolitis; Chronic wheezing; Congenital diaphragmatic hernia; Recurrence; Respiratory syncytial virus

Indexed keywords

PALIVIZUMAB; POLITEF;

ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CONGENITAL DIAPHRAGM HERNIA; DETERIORATION; DIAGNOSTIC IMAGING; DISEASE SEVERITY; FETUS ECHOGRAPHY; FOLLOW UP; HOSPITALIZATION; HUMAN; LUNG HYPOPLASIA; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; REOPERATION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK FACTOR; VIRUS INFECTION; WHEEZING;

FEMALE; HERNIA, DIAPHRAGMATIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; RECURRENCE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RISK FACTORS;

EID: 50249090467     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2008.02580.x     Document Type: Article

References (19)

1. Cortes RA, Keller RL, Townsend T et al. Survival of severe congenital diaphragmatic hernia has morbid consequences. J. Pediatr. Surg. 2005 40 : 36 46.
2. Bagolan P, Casaccia G, Crescenzi F, Nahom A, Trucchi A, Gliorlandino C. Impact of a current treatment on outcome of high-risk congenital diaphragmatic hernia. J. Pediatr. Surg. 2004 39 : 313 18.
3. Hajer GF, vd Staak FH, de Haan AF, Festen C. Recurrent congenital diaphragmatic hernia; which factors are involved? Eur. J. Pediatr. Surg. 1998 8 : 329 33.
4. Bonner D, Schmaltz AA, Feltes TF. Infection by the respiratory syncytial virus in infants and young children at high risk. Cardiol. Young 2005 15 : 256 65.
5. Simoes EA. Respiratory syncytial virus infection. Lancet 1999 354 : 847 52.
6. The IMpact-RSV study group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998 102 : 531 7.
7. Kamata S, Usui N, Kamiyama M et al. Long-term follow-up of patients with high-risk congenital diaphragmatic hernia. J. Pediatr. Surg. 2005 40 : 1833 8.
8. Muratore CS, Kharasch V, Lund DP et al. Pulmonary morbidity in 100 survivors of congenital diaphragmatic hernia monitored in a multidisciplinary clinic. J. Pediatr. Surg. 2001 36 : 133 40.
9. Greenough A, Broughton S. Chronic manifestations of respiratory syncytial virus infection in premature infants. Pediatr. Infect. Dis. J. 2005 24 : S184 8.
10. Sigurs N, Gustafsson PM, Bjarnason R et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 2005 171 : 137 41.
11. Dakhama A, Lee YM, Gelfand EW. Virus-induced airway dysfunction, pathogenesis and biomechanisms. Pediatr. Infect. Dis. J. 2005 24 : S159 69.
12. Mejias A, Chavez-Bueno S, Jafri HS, Ramilo O. Respiratory syncytial virus infections: Old challenges and new opportunities. Pediatr. Infect. Dis. J. 2005 24 : S189 97.
13. Shehata SMK, Tibboel D, Sharma HS, Mooi WJ. Impaired structural remodeling of pulmonary arteries in newborns with congenital diaphragmatic hernia: A histological study of 29 cases. J. Pathol. 1999 189 : 112 18.
14. Masumoto K, de Rooij JD, Suita S, Rottier R, Tibboel D, de Krijger RR. The distribution of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the lungs congenital diaphragmatic hernia patients and age-matched controls. Histopathology 2006 48 : 588 95.
15. Rowe DH, Stolar CJ. Recurrent diaphragmatic hernia. Semin. Pediatr. Surg. 2003 12 : 107 9.
16. Van Meurs KP, Robbins ST, Reed VL et al. Congenital diaphragmatic hernia: Long-term outcome in neonates treated with extracorporeal membrane oxygenation. J. Pediatr. 1993 122 : 893 9.
17. Wischermman A, Holschneider AM, Hubner U. Long term follow-up of children with diaphragmatic hernia. Eur. J. Pediatr. Surg. 1995 5 : 13 18.
18. Feltes TF, Cabalka AK, Meissner HC et al. Cardiac Synagis Study Group: Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J. Pediatr. 2003 143 : 532 40.
19. Emerick K, Cunningham M, Hartnick C. The potential impact of palivizumab on pediatric airway reconstruction. Am. J. Otolaryngol. 2006 27 : 9 12.